Prevalence of prostate cancer in end-stage renal disease patients

Urologia Internationalis

Volumn 80, Issue 4, 2008, Pages 419-424

  Kamata, Toshiro ^a   Fushimi, Kiyohide ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

End stage renal disease; Hemodialysis; Prevalence; Prostate cancer; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CALCULATION; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HEMODIALYSIS; HUMAN; JAPAN; KIDNEY FAILURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SCREENING TEST;

AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASM STAGING; PREVALENCE; PROBABILITY; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REFERENCE VALUES; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 46249114363     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000132701     Document Type: Article

References (18)

1. Port FK, Ragheb NE, Schwartz AG, et al: Neoplasms in dialysis patients: A population-based study. Am J Kidney Dis 1989;14:119-123.
2. Cormier L, Lechevallier E, Barrou B, et al: Diagnosis and treatment of prostate cancers in renal-transplant recipients. Transplantation 2003;75:237-239.
3. Maisonneuve P, Agodoa L, Gellert R, et al: Cancer in patients on dialysis for end-stage renal disease: an international collaborative study. Lancet 1999;354:93-99.
4. Labrie F, Dupont A, Suburu R, et al: Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 1992;147:846-852.
5. Catalona WJ, Richie JP, Ahmann FR, et al: Comparison of digital rectal examination of prostate cancer: results of multicenter clinical trial of 6,630 men. J Urol 1994;151:1283-1290.
6. Labrie F, Candas B, Dupont A, et al: Screening decreases prostate cancer death: first analysis of the 1998 Quebec prospective randomized controlled trial. Prostate 1999;38:83-91.
7. Frankel S, Smith DG, Donovan J, et al: Screening for prostate cancer. Lancet 2003;361:1122-1128.
8. Djavan B, Shariat S, Ghawidel K, et al: Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis? Urology 1999;53:1169-1174.
9. Denisman A, Killic S, Kukul E, et al: Do renal failure and hemodialysis have any effect on the elimination of free and total prostate-specific antigen? Eur Urol 2000;37:579-581.
10. Wolff JM, Ting O, Borchers H, et al: Serum levels of prostate specific antigen in men on hemodialysis. Anticancer Res 2000;20:5191-5193.
11. Tzanakis I, Kazoulis K, Girousis N, et al: Prostate-specific antigen in hemodialysis patients and the influence of dialysis in its levels. Nephron 2002;90:230-233.
12. Osterling JE, Kumamoto Y, Tsukamoto T, et al: Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 1993;75:347-353.
13. Andriole GL, Levin DL, Crawford ED, et al: Prostate Cancer Screening in the prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: finding from the initial screening round of a randomized trial. J Natl Cancer Inst 2005;97:433-438.
14. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
15. Bartsch G, Horninger W, Klocker H, et al: Prostate cancer mortality after introduction of prostate specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 2001;58:417-424.
16. Saruki K, Sekihara T, Mashimo M, et al: Leuprorelin acetate blood levels and dialysance after the administration of sustained-release leuprorelin acetate in a dialysis case complicated by prostate cancer. Prostate 1998;34:191-194.
17. Prostate-specific antigen (PSA) best practice policy: American Urological Association (AUA). Oncology 2000;14:267-272, 277-278, 280 passim.
18. Smith RA, Cokkinides V, Eyre HJ: American Cancer Society Guidelines for the early detection of cancer, 2006. CA Cancer J Clin 2006;56:11-25.